PHARMACODYNAMICALLY OPTIMIZED ERYTHROPOIETIN TREATMENT COMBINED WITH PHLEBOTOMY REDUCTION PREDICTED TO ELIMINATE BLOOD TRANSFUSIONS IN SELECTED PRETERM INFANTS

BACKGROUND: Preterm very low birth weight (VLBW) infants weighing <1.5 kg at birth develop anemia requiring red blood cell transfusions (RBCTx). Because laboratory blood loss is a primary cause of anemia leading to RBCTx in VLBW infants, our goal was to simulate the extent to which RBCTx can be r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pediatr Res
Autores principales: Rosebraugh, Matthew R., Widness, John A., Nalbant, Demet, Cress, Gretchen, Veng-Pedersen, Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4418561/
https://ncbi.nlm.nih.gov/pubmed/24216541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pr.2013.213
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares